Reply to Aitken et al., "Should Piperacillin-Tazobactam Be Used as Definitive Therapy against Enterobacteriaceae Harboring Inducible AmpC β-Lactamases?"
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY（2017）
关键词
enterobacteriaceae harboring inducible ampc,piperacillin-tazobactam
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要